Graziani, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.987
AS - Asia 2.913
EU - Europa 2.711
SA - Sud America 678
AF - Africa 94
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.398
Nazione #
US - Stati Uniti d'America 2.878
SG - Singapore 1.344
CN - Cina 832
DE - Germania 772
BR - Brasile 575
IT - Italia 512
SE - Svezia 457
FR - Francia 208
GB - Regno Unito 162
IE - Irlanda 152
VN - Vietnam 139
IN - India 113
ID - Indonesia 101
UA - Ucraina 82
RU - Federazione Russa 75
FI - Finlandia 71
HK - Hong Kong 62
CA - Canada 56
KR - Corea 51
BD - Bangladesh 42
AR - Argentina 40
PL - Polonia 37
TR - Turchia 37
AT - Austria 36
ZA - Sudafrica 36
IQ - Iraq 34
JP - Giappone 33
NL - Olanda 33
MX - Messico 32
ES - Italia 20
IR - Iran 19
BE - Belgio 16
CI - Costa d'Avorio 16
EC - Ecuador 15
JO - Giordania 13
PK - Pakistan 13
VE - Venezuela 13
LT - Lituania 12
UZ - Uzbekistan 11
IL - Israele 10
CL - Cile 9
CO - Colombia 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
MA - Marocco 8
AU - Australia 7
EG - Egitto 7
KE - Kenya 6
NP - Nepal 6
PE - Perù 6
RO - Romania 6
CU - Cuba 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
GR - Grecia 5
HU - Ungheria 5
KZ - Kazakistan 5
PT - Portogallo 5
PY - Paraguay 5
TN - Tunisia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
LV - Lettonia 4
MD - Moldavia 4
MK - Macedonia 4
PS - Palestinian Territory 4
UY - Uruguay 4
AL - Albania 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JM - Giamaica 3
KH - Cambogia 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
HR - Croazia 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
Totale 9.382
Città #
Singapore 663
Chandler 472
Ashburn 411
Beijing 187
Hefei 151
New York 149
Dublin 142
Rome 121
Los Angeles 93
Jakarta 90
Milan 79
Marseille 63
San Mateo 63
Hong Kong 60
Munich 59
The Dalles 59
Nanjing 56
Boston 55
Frankfurt am Main 54
Jacksonville 54
São Paulo 54
Ho Chi Minh City 49
Moscow 49
Seoul 49
Ann Arbor 45
Kent 42
Wilmington 42
London 37
Nürnberg 36
Dallas 34
Hanoi 33
Houston 33
Helsinki 31
Nuremberg 31
Princeton 30
Bremen 29
Buffalo 28
Seattle 27
Stockholm 25
Tokyo 24
Cattolica 23
Warsaw 22
Brooklyn 19
Chennai 19
Johannesburg 19
Chicago 18
Dearborn 18
Nanchang 18
North Bergen 18
Rio de Janeiro 18
Vienna 18
Denver 17
Düsseldorf 17
Pune 17
Redwood City 17
Roubaix 17
Toronto 17
Abidjan 16
Atlanta 16
Brussels 16
Washington 16
Mexico City 15
Orem 15
Poplar 15
Santa Clara 15
Woodbridge 15
Phoenix 14
Tianjin 14
Amman 13
Baghdad 13
Lauterbourg 13
Lawrence 13
Turku 13
Belo Horizonte 12
Bologna 12
Enterprise 12
Lappeenranta 12
Montreal 12
Salvador 12
San Francisco 12
Bexley 11
Palermo 11
Fairfield 10
Falls Church 10
Guarulhos 10
Mumbai 10
Paris 10
Tashkent 10
Augusta 9
Brasília 9
Curitiba 9
Izmir 9
Las Vegas 9
Leawood 9
Amsterdam 8
Andover 8
Boardman 8
Detroit 8
Haiphong 8
Hyderabad 8
Totale 4.621
Nome #
Paradoxical preservation of vascular function in severe obesity 335
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 201
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 199
Endothelial progenitor cells in morbid obesity 190
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects 183
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 180
Thromboxane production in morbidly obese subjects 167
Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives 150
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 149
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions 144
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 144
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 142
Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study 142
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 138
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy 130
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery" 129
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 128
Heart Team e malattie valvolari: L’importanza di un approccio multidisciplinare 121
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 120
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 116
Right ventricular strain in Anderson-Fabry disease 111
Early Right Heart Chambers Reverse Remodeling in Patients Operated in Adulthood for Congenital Lesions Associated with Right Heart Chambers Enlargement 111
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial 110
Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease 108
Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome 104
Acute haemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis 104
When compassionate is appropriate for end-stage aortic valve stenosis? 102
Performance, clinical outcomes and implementation of an original heart valve clinic model 101
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 100
Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve 97
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 96
An uplifted destiny for mucopolysaccharidosis type I with heart involvement 96
Inflammation across the spectrum of hypertrophic cardiac phenotypes 95
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 94
Right ventricle systolic function and right ventricle-pulmonary artery coupling in patients with severe aortic stenosis and the early impact of TAVI 94
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 92
Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease 91
A multimodal approach to predict prosthesis-patient mismatch in patients undergoing valve-in-valve trans-catheter aortic valve implantation 89
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 89
Successful Transcatheter Treatment of Left Pulmonary Artery to Left Atrium Communication Diagnosed in Adulthood 88
Unexpected Left Ventricle Pseudoaneurysm With Unusual Origin: History of a Diseased Annulus Broken Into a Diseased Myocardium 87
Valvular heart disease and cardiomyopathy: reappraisal of their interplay 87
Diagnostic role of echocardiography in patients admitted to the emergency room with suspect no-ST-segment elevation acute myocardial infarction 87
Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy 87
Right ventricular strain in Fabry disease: Prognostic implications 86
Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy 86
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 84
Echocardiographic left atrial stiffness index predicts high left ventricular filling pressures in patients with acute heart failure: an observational study 84
Pulmonary artery sling in a 22-month-old boy with 18q deletion syndrome: A rare but possible association 84
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study 84
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 84
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 83
Diagnosis and management of peripartum cardiomyopathy and recurrence risk 82
Pulmonary congestion assessed by lung ultrasound in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: Prevalence and prognostic implications 81
Left atrial strain analysis improves left ventricular filling pressures non-invasive estimation in the acute phase of Takotsubo syndrome 81
Early Hemodynamic and Structural Impact of Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation 81
Evaluation of Adults With Congenital Heart Disease 79
Association of Cardiac Sarcoidosis and Ulcerative Colitis: A Case Report and a Brief Review of the Literature 78
Right ventricle-pulmonary artery coupling in repaired tetralogy of Fallot with pulmonary regurgitation: Clinical implications 77
Right atrial strain in Anderson-Fabry disease 77
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 77
Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: The role of thrombosis, fibrinolysis and atherosclerotic burden. 75
Global longitudinal strain for prediction of mortality in ST-segment elevation myocardial infarction and aortic stenosis patients: two sides of the same coin 74
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 74
Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis 72
Temporal trends of frame expansion and paravalvular leak reduction after transcatheter aortic valve replacement with self-expandable prostheses 71
Cardiac Magnetic Resonance Features of Fabry Disease: From Early Diagnosis to Prognostic Stratification 71
Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis 71
Undiagnosed Severe Late Complications of Repaired Tetralogy of Fallot 71
An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement 71
Evolution and Prognostic Impact of Right Ventricular-Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement 70
Impact of severe valvular heart disease in adult congenital heart disease patients 70
Comparison of De-Kay repair versus De Vega suture for functional tricuspid regurgitation: a preliminary experience 68
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study 67
Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease 67
Transthoracic Echocardiography in Assessing Patients with Suspected Infective Endocarditis (TEASE): An Exploratory Study 66
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 64
Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin 63
Atypical Thrombosis Following Mitral Transcatheter Edge-to-Edge Repair: Face to Face Between Scar and Clip 63
Pregnancy in hypertrophic cardiomyopathy: New data, old questions 62
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 62
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 61
The Heart in Fabry Disease: Mechanisms Beyond Storage and Forthcoming Therapies 61
A Novel Hemodynamic Index Characterizing Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: The MPF 61
Echocardiography in Anderson-Fabry Disease 57
Management, Flow, and Outcomes of Patients with Aortic Stenosis Followed by a Heart Valve Clinic: The Untold "Behind the Scene" from a High-Volume, Real-World Experience 57
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 57
Non-invasive imaging of ventricular-atrial fistulization secondary to infective rupture of caseous calcification of the mitral annulus 57
Early cardiac mechanics abnormalities in patients with mitochondrial diseases 56
An unusual case of mitral valve chordal rupture 56
Dynamic modulation of coronary arterio-venous communications 56
Modified Warden procedure in adult with partial anomalous pulmonary venous connection after previous atrial septal defect repair 56
Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study 55
Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction 54
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 53
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 51
Right ventricular to pulmonary artery coupling and prognosis in transthyretin cardiac amyloidosis 48
Subclinical dysfunction of remote myocardium is related to high NT-proBNP and affects global contractility at follow-up, independently of infarct area 48
Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease 48
Généreux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation 47
Totale 9.327
Categoria #
all - tutte 43.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 17 39 10 23 8 33 2
2021/2022500 11 22 4 32 47 13 8 97 22 44 101 99
2022/20231.445 160 152 119 203 66 167 95 138 144 112 67 22
2023/2024977 40 240 49 59 51 178 42 35 34 42 90 117
2024/20252.208 35 59 150 74 160 67 82 92 324 195 585 385
2025/20263.111 818 233 346 671 804 239 0 0 0 0 0 0
Totale 9.518